Chapman, SR, Fitzpatrick, RW and Aladul, MI (2016) Did Cost Inhibit the Uptake of More potent Statins? Pharmacoepidemiology and Drug Safety, 25 (S2). pp. 3-23. ISSN 1099-1557

WarningThere is a more recent version of this item available.
Full text not available from this repository.
Item Type: Article
Additional Information: Abstract of paper presented at Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 “Ethics, Economics and the Future of Medicines – A Population Perspective” This is the peer reviewed version of the following abstract: Anon, 2016. Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 “Ethics, Economics and the Future of Medicines - A Population Perspective.” Pharmacoepidemiol Drug Saf, 25, pp.3–23, which has been published in final form at http://dx.doi.org/10.1002/pds.4019 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Uncontrolled Keywords: statins, simvastatin, atorvastatin, generics, prescribing
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 18 May 2016 14:12
Last Modified: 11 Jun 2018 13:50
URI: http://eprints.keele.ac.uk/id/eprint/1737

Available Versions of this Item

Actions (login required)

View Item View Item